Even broader roles for NAC1 and BCL6 might exist in ovarian cancer, as ingenuity pathway analysis has revealed the upregulation of IL-17, IL-8, and IL-6 signaling pathways, which were reported to be correlated with novel functions in driving tumor growth and stemness [29–31]. Here, IL17A is linked to ovarian carcinoma.